Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
EUROPEAN QUALITY STANDARDS: Produced according to the highest European quality standards and tested in independent laboratories
Canine Parvovirus Monoclonal Antibody CPMA (now Trutect TM ) is the first and only monoclonal antibody (mAb) treatment that targets canine parvovirus (CPV) and has been shown to be effective for passive immunity (i.e
Key ingredient Formulated with Niacinamide (50,000ppm) to suppress melanin transfer and brighten uneven tone , paired with Glutathione (0.3ppm) for powerful antioxidant protection and spot fading
The benzyl alcohol preservative prevents bacterial growth but should be avoided for cell culture applications
Interest has only grown into 2025 and 2026, with newer work on synthesis routes, stem cell and matrix effects, and broader gene-expression mapping (one analysis flagged modulation of more than 4,000 genes)
US$ 20.84
US$ 24.86
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 28.20
US$ 24.93
